Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Scott A. Wagenberg, MD, is part of the Cole Eye Institute at Hillcrest Hospital. He was in private practice at Hillcrest Hospital from 2000-2010. He joined the Cole Eye Institute in 2010.
Dr. Wagenberg earned his medical degree at the University of Michigan. He did an ophthalmology residency at Case Western Reserve University. He completed a fellowship in corneal and refractive surgery at the Corneal Consultants of Indianapolis. He was board certified in Ophthalmology in 2001.
Dr. Wagenberg specializes in diseases and surgery of the cornea. He is at the leading edge of corneal transplantation including endothelial keratoplasty (DMEK and DSAEK), deep anterior lamellar keratoplasty (DALK), and penetrating keratoplasty. He has helped to design a keratome for the purpose of preparing corneal tissue for endothelial keratoplasty. He has lectured at regional, national and international corneal conferences. He has performed live surgery at an international corneal conference. In addition to his interest in corneal transplantation, he has an interest in ocular surface reconstruction including the use of amniotic membrane for the repair of the corneal surface.
In addition, to his interest in corneal diseases and surgery, Dr. Wagenberg also practices comprehensive ophthalmology including the treatment of cataracts and glaucoma, contact lens fitting, dry eye, and infections and inflammation of the eye.
Dr. Wagenberg is a member of the American Academy of Ophthalmology and the Corneal Society. He is listed in "The Best Doctors in America."
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/30/2015, Dr. Wagenberg has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.